Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Dr Geer Hubregtse 02/11/2016 Dr Karen Luyt 02/11/2016 09 September 2025 The principal activity of the Company during the financial year was the provision of medical consultancy services. 10458771 2025-03-31 10458771 bus:Director1 2025-03-31 10458771 bus:Director2 2025-03-31 10458771 2024-03-31 10458771 core:CurrentFinancialInstruments 2025-03-31 10458771 core:CurrentFinancialInstruments 2024-03-31 10458771 core:ShareCapital 2025-03-31 10458771 core:ShareCapital 2024-03-31 10458771 core:RetainedEarningsAccumulatedLosses 2025-03-31 10458771 core:RetainedEarningsAccumulatedLosses 2024-03-31 10458771 core:OfficeEquipment 2024-03-31 10458771 core:OfficeEquipment 2025-03-31 10458771 2023-03-31 10458771 bus:OrdinaryShareClass1 2025-03-31 10458771 bus:OrdinaryShareClass2 2025-03-31 10458771 2024-04-01 2025-03-31 10458771 bus:FilletedAccounts 2024-04-01 2025-03-31 10458771 bus:SmallEntities 2024-04-01 2025-03-31 10458771 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 10458771 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10458771 bus:Director1 2024-04-01 2025-03-31 10458771 bus:Director2 2024-04-01 2025-03-31 10458771 core:OfficeEquipment 2024-04-01 2025-03-31 10458771 2023-04-01 2024-03-31 10458771 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 10458771 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 10458771 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 10458771 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 10458771 (England and Wales)

DR KAREN LUYT LTD

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

DR KAREN LUYT LTD

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

DR KAREN LUYT LTD

BALANCE SHEET

As at 31 March 2025
DR KAREN LUYT LTD

BALANCE SHEET (continued)

As at 31 March 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 8,518 5,802
8,518 5,802
Current assets
Debtors 4 4,982 2,068
Cash at bank and in hand 13,529 16,888
18,511 18,956
Creditors: amounts falling due within one year 5 ( 6,013) ( 5,700)
Net current assets 12,498 13,256
Total assets less current liabilities 21,016 19,058
Provision for liabilities 6 ( 1,618) ( 1,102)
Net assets 19,398 17,956
Capital and reserves
Called-up share capital 7 100 100
Profit and loss account 19,298 17,856
Total shareholders' funds 19,398 17,956

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Dr Karen Luyt Ltd (registered number: 10458771) were approved and authorised for issue by the Board of Directors on 09 September 2025. They were signed on its behalf by:

Dr Geer Hubregtse
Director
DR KAREN LUYT LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
DR KAREN LUYT LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Dr Karen Luyt Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Greenway Barton, Rhode, Bridgwater, TA5 2AD, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of of approving these financial statements. The directors have a reasonable expectation that the company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Therefore, the directors are satisfied that the going concern basis of preparation is correct.

Turnover

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the
ordinary course of the company's activities.

The company recognises revenue when services have been delivered.

Employee benefits

Defined contribution schemes
The company contributes to the directors' personal pension schemes. The assets of the schemes are held separately from those of the company. The contributions payable are charges to the profit and loss account.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a reducing balance basis over its expected useful life, as follows:

Office equipment 15 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Office equipment Total
£ £
Cost
At 01 April 2024 7,649 7,649
Additions 4,694 4,694
Disposals ( 1,158) ( 1,158)
At 31 March 2025 11,185 11,185
Accumulated depreciation
At 01 April 2024 1,847 1,847
Charge for the financial year 936 936
Disposals ( 116) ( 116)
At 31 March 2025 2,667 2,667
Net book value
At 31 March 2025 8,518 8,518
At 31 March 2024 5,802 5,802

4. Debtors

2025 2024
£ £
Trade debtors 4,320 1,410
Prepayments 662 658
4,982 2,068

5. Creditors: amounts falling due within one year

2025 2024
£ £
Amounts owed to directors 2,496 1,872
Accruals 1,350 1,260
Taxation and social security 2,167 2,568
6,013 5,700

6. Deferred tax

2025 2024
£ £
At the beginning of financial year ( 1,102) ( 942)
Charged to the Statement of Income and Retained Earnings ( 516) ( 160)
At the end of financial year ( 1,618) ( 1,102)

7. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
75 Ordinary A shares of £ 1.00 each 75 75
25 Ordinary B shares of £ 1.00 each 25 25
100 100